COVID exacerbated the gender inequities that exist in our workplace and society. We are at risk of losing an entire generation of women in academics. Outstanding work by @angiefagerlin @RebeccaKDelaney @UofUHealth@UofUPHS
Colon Cancer Awareness Month, wearing blue to support! Beswick Lab and collaborating labs, O'Connell Lab and Zhu lab (Utah State) @huntsmancancer @NeliMUlric @helops79@ellenbeswick@UofU3i
Our latest COVID manuscript is now out implicating cytokine/soluble factor networks promoting vasculitis and stromal remodelling with some unexpected gender differences. Thanks to @RMP_Utah@ellenbeswick and others not on twitter for this!
https://t.co/03bx8ojHmS
Clues to COVID-19 Complications Come from NET-like Inflammatory Response - An overactive defense response may lead to increased blood clotting, disease severity, and death from COVID-19. https://t.co/d5DKEc7ok8 via @UofUHealth
Clues to COVID-19 Complications Come from NET-like Inflammatory Response - An overactive defense response may lead to increased blood clotting, disease severity, and death from COVID-19. @EAMiddleton5 @ccyost1 @UofUHealth
I would like to be the first to welcome Heloisa Soares @helops79 to @huntsmancancer I am honored that she chose to join us in Utah. See you in a day or two Isa!!
Dr. Ellen Beswick (@ellenbeswick) has been working hard to create translational teams in the Division of Gastroenterology, Hepatology & Nutrition (@UofUInternalMed). Learn more about her work and the new GI Tissue Bank here: https://t.co/mvYIxSaEWl #MedTwitter#SciTwitter#GI
This week's #Meet3iMonday spotlight is Dr. Ellen Beswick (@ellenbeswick) from @UofUInternalMed - GI Division. Dr. Beswick's research is on novel immune targets for #GI#cancers that can be used in translational approaches to dev. new Tx. #academictwitter https://t.co/VaHYmCaliA
It's time for #TeamScience Tuesday! This week we celebrate the collaboration between Dr. Ellen Beswick (@ellenbeswick) and Dr. Kathy Peterson from @UofUInternalMed - GI Division. They are working on cytokine networking in #cancer and eosinophilic disease 2 develop new Txs.